ICCC
ImmuCell Corporation
NASDAQ: ICCC · HEALTHCARE · BIOTECHNOLOGY
$8.44
+1.08% today
Updated 2026-04-29
Market cap
$74.64M
P/E ratio
—
P/S ratio
2.70x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$5 – $8
Volume
0.0M
ImmuCell Corporation (ICCC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.36M | $349557.00 | $53137.00 | $-109665.00 | $-808613.00 | $-37315.00 | $344390.00 | $1.10M | $302364.00 | $2.90M | $-323902.00 | $1.18M | $-373404.00 | $233511.00 | $1.32M | $954170.00 | $-1.54M | $-4.67M | $357903.00 | $2.48M |
| Capital expenditures | $1.30M | $1.53M | $410624.00 | $459548.00 | $116547.00 | $243735.00 | $275395.00 | $597697.00 | $1.54M | $2.72M | $3.59M | $17.76M | $2.03M | $1.39M | $4.07M | $2.61M | $3.98M | $1.89M | $465725.00 | $1.25M |
| Depreciation | $278522.00 | $788896.00 | $399104.00 | $424440.00 | $419511.00 | $418372.00 | $402516.00 | $417201.00 | $448921.00 | $529261.00 | $802379.00 | $904435.00 | $1.52M | $2.27M | $2.35M | $2.46M | $2.49M | $2.72M | $2.69M | — |
| Stock-based comp | $2892.00 | $6594.00 | $55285.00 | $94062.00 | $29513.00 | $38172.00 | $35985.00 | $31359.00 | $30004.00 | $23222.00 | $67399.00 | $199783.00 | $344016.00 | $313144.00 | $253135.00 | $144313.00 | $266244.00 | $368866.00 | $326000.00 | $295871.00 |
| Free cash flow | $54807.00 | $-1.18M | $-357487.00 | $-569213.00 | $-925160.00 | $-281050.00 | $68995.00 | $500963.00 | $-1.23M | $181047.00 | $-3.91M | $-16.58M | $-2.40M | $-1.16M | $-2.76M | $-1.65M | $-5.52M | $-6.57M | $-107822.00 | $1.22M |
| Investing cash flow | $-3.16M | $-481369.00 | $-45847.00 | $-215445.00 | $266453.00 | $-1.19M | $1.66M | $-1.34M | $-1.54M | $-4.62M | $-4.42M | $-12.27M | $-1.79M | $-3.40M | $-2.57M | $-1.60M | $-3.96M | $-1.89M | $-461225.00 | — |
| Financing cash flow | $146294.00 | $-24405.00 | $2.00 | $100671.00 | $965655.00 | $614581.00 | $-114792.00 | $-159297.00 | $-187163.00 | $2.44M | $8.32M | $9.75M | $889615.00 | $6.94M | $1.91M | $3.88M | $1.11M | $1.75M | $2.88M | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-617469.00 | $1.89M | $-403334.00 | $-1.42M | $723300.00 | $3.58M | $-1.35M | $-1.28M | $3.77M | $656644.00 | — | — | — | — | — |